File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/S0964-1955(96)00038-3
- Scopus: eid_2-s2.0-0030987114
- PMID: 9192550
- WOS: WOS:A1997WR21500007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in human benign and malignant epithelial lesions of the parotid gland
Title | The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in human benign and malignant epithelial lesions of the parotid gland |
---|---|
Authors | |
Keywords | Diagnosis Morphometry Neoplasia PCNA Prognosis Proliferation Salivary gland |
Issue Date | 1997 |
Publisher | Pergamon. The Journal's web site is located at http://www.elsevier.com/locate/oraloncology |
Citation | European Journal Of Cancer Part B: Oral Oncology, 1997, v. 33 n. 1, p. 29-35 How to Cite? |
Abstract | Immunoreactivity of proliferating cell nuclear antigen (PCNA) was assessed in formalin-fixed, paraffin-embedded sections from human normal parotid gland (N; n = 12), chronic sialadenitis (CS; n = 8), Warthin's tumour (W; n = 10), benign pleomorphic adenoma (BPA; n = 11), mucoepidermoid carcinoma (MEC; n = 14), carcinoma in pleomorphic adenoma (CPA; n = 10) and adenoid cystic carcinoma (ACC; n = n) of the parotid gland, using the monoclonal antibody PC 10. The morphometric parameters measured comprised PCNA labelling indices (PI = the numerical percentage of PCNA positive nuclei) and volume densities of PCNA positive nuclei (V(v), PEP = the relative volume of positive nuclei per unit volume of reference epithelium). All parameters were expressed in relation to total positive, as well as to strongly- and weakly-positive nuclei. In general, the values of PCNA parameters increased progressively in benign lesions in comparison with the N group, and in malignant neoplasms in comparison with non-neoplastic groups and benign lesions. The strongly-positive parameters showed more statistically significant differences than weakly-positive ones, suggesting that weakly-stained nuclei may include some non-cycling cells and, therefore, that weakly-positive parameters may not be reliable proliferation markers. Values for all parameters in CPA were significantly higher than those in BPA, suggesting that these parameters may be used as diagnostic discriminators. Spearman rank correlation analysis showed a highly positive correlation between the morphometric parameters and the severity of the lesions. Furthermore, the mean values of PI(SP) were significantly higher in patients who died of the malignant tumours than in those patients who survived. Our results indicate that PCNA indices might be useful markers for discriminating between benign (BPA) and malignant tumours of the parotid gland and that the parameter PI(SP) may have prognostic applications. |
Persistent Identifier | http://hdl.handle.net/10722/149563 |
ISSN | |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Zhu, Q | en_US |
dc.contributor.author | White, FH | en_US |
dc.contributor.author | Tipoe, GL | en_US |
dc.date.accessioned | 2012-06-26T05:55:18Z | - |
dc.date.available | 2012-06-26T05:55:18Z | - |
dc.date.issued | 1997 | en_US |
dc.identifier.citation | European Journal Of Cancer Part B: Oral Oncology, 1997, v. 33 n. 1, p. 29-35 | en_US |
dc.identifier.issn | 0964-1955 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/149563 | - |
dc.description.abstract | Immunoreactivity of proliferating cell nuclear antigen (PCNA) was assessed in formalin-fixed, paraffin-embedded sections from human normal parotid gland (N; n = 12), chronic sialadenitis (CS; n = 8), Warthin's tumour (W; n = 10), benign pleomorphic adenoma (BPA; n = 11), mucoepidermoid carcinoma (MEC; n = 14), carcinoma in pleomorphic adenoma (CPA; n = 10) and adenoid cystic carcinoma (ACC; n = n) of the parotid gland, using the monoclonal antibody PC 10. The morphometric parameters measured comprised PCNA labelling indices (PI = the numerical percentage of PCNA positive nuclei) and volume densities of PCNA positive nuclei (V(v), PEP = the relative volume of positive nuclei per unit volume of reference epithelium). All parameters were expressed in relation to total positive, as well as to strongly- and weakly-positive nuclei. In general, the values of PCNA parameters increased progressively in benign lesions in comparison with the N group, and in malignant neoplasms in comparison with non-neoplastic groups and benign lesions. The strongly-positive parameters showed more statistically significant differences than weakly-positive ones, suggesting that weakly-stained nuclei may include some non-cycling cells and, therefore, that weakly-positive parameters may not be reliable proliferation markers. Values for all parameters in CPA were significantly higher than those in BPA, suggesting that these parameters may be used as diagnostic discriminators. Spearman rank correlation analysis showed a highly positive correlation between the morphometric parameters and the severity of the lesions. Furthermore, the mean values of PI(SP) were significantly higher in patients who died of the malignant tumours than in those patients who survived. Our results indicate that PCNA indices might be useful markers for discriminating between benign (BPA) and malignant tumours of the parotid gland and that the parameter PI(SP) may have prognostic applications. | en_US |
dc.language | eng | en_US |
dc.publisher | Pergamon. The Journal's web site is located at http://www.elsevier.com/locate/oraloncology | en_US |
dc.relation.ispartof | European Journal of Cancer Part B: Oral Oncology | en_US |
dc.subject | Diagnosis | - |
dc.subject | Morphometry | - |
dc.subject | Neoplasia | - |
dc.subject | PCNA | - |
dc.subject | Prognosis | - |
dc.subject | Proliferation | - |
dc.subject | Salivary gland | - |
dc.subject.mesh | Adenocarcinoma - Metabolism | en_US |
dc.subject.mesh | Adenolymphoma - Metabolism | en_US |
dc.subject.mesh | Adenoma, Pleomorphic - Metabolism | en_US |
dc.subject.mesh | Carcinoma, Adenoid Cystic - Metabolism | en_US |
dc.subject.mesh | Carcinoma, Mucoepidermoid - Metabolism | en_US |
dc.subject.mesh | Follow-Up Studies | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Immunohistochemistry | en_US |
dc.subject.mesh | Parotid Diseases - Metabolism - Pathology | en_US |
dc.subject.mesh | Parotid Gland - Metabolism | en_US |
dc.subject.mesh | Parotid Neoplasms - Metabolism - Pathology | en_US |
dc.subject.mesh | Proliferating Cell Nuclear Antigen - Metabolism | en_US |
dc.subject.mesh | Sialadenitis - Metabolism | en_US |
dc.subject.mesh | Statistics, Nonparametric | en_US |
dc.subject.mesh | Survival Analysis | en_US |
dc.subject.mesh | Tumor Markers, Biological - Metabolism | en_US |
dc.title | The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in human benign and malignant epithelial lesions of the parotid gland | en_US |
dc.type | Article | en_US |
dc.identifier.email | Tipoe, GL:tgeorge@hkucc.hku.hk | en_US |
dc.identifier.authority | Tipoe, GL=rp00371 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/S0964-1955(96)00038-3 | en_US |
dc.identifier.pmid | 9192550 | - |
dc.identifier.scopus | eid_2-s2.0-0030987114 | en_US |
dc.identifier.hkuros | 21939 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0030987114&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 33 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.spage | 29 | en_US |
dc.identifier.epage | 35 | en_US |
dc.identifier.isi | WOS:A1997WR21500007 | - |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.scopusauthorid | Zhu, Q=16026167700 | en_US |
dc.identifier.scopusauthorid | White, FH=7202578907 | en_US |
dc.identifier.scopusauthorid | Tipoe, GL=7003550610 | en_US |
dc.identifier.issnl | 0964-1955 | - |